Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Abatacept
Related studies linked through entity extraction aliases.
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
- Status
- UNKNOWN
- Phase
- PHASE3
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access for Abatacept
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
COVID-19 VaccinE Response in Rheumatology Patients
- Status
- COMPLETED
- Phase
- PHASE4